Cargando…
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review
Pituitary tumors (PT) are mostly benign, although occasionally they demonstrate aggressive behavior, invasion of surrounding tissues, rapid growth, resistance to conventional treatments, and multiple recurrences. The pathogenesis of PT is still not fully understood, and the factors responsible for i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341524/ https://www.ncbi.nlm.nih.gov/pubmed/37446128 http://dx.doi.org/10.3390/ijms241310952 |
_version_ | 1785072282326007808 |
---|---|
author | Derwich, Aleksandra Sykutera, Monika Bromińska, Barbara Rubiś, Błażej Ruchała, Marek Sawicka-Gutaj, Nadia |
author_facet | Derwich, Aleksandra Sykutera, Monika Bromińska, Barbara Rubiś, Błażej Ruchała, Marek Sawicka-Gutaj, Nadia |
author_sort | Derwich, Aleksandra |
collection | PubMed |
description | Pituitary tumors (PT) are mostly benign, although occasionally they demonstrate aggressive behavior, invasion of surrounding tissues, rapid growth, resistance to conventional treatments, and multiple recurrences. The pathogenesis of PT is still not fully understood, and the factors responsible for its invasiveness, aggressiveness, and potential for metastasis are unknown. RAF/MEK/ERK and mTOR signaling are significant pathways in the regulation of cell growth, proliferation, and survival, its importance in tumorigenesis has been highlighted. The aim of our review is to determine the role of the activation of PI3K/AKT/mTOR and RAF/MEK/ERK pathways in the pathogenesis of pituitary tumors. Additionally, we evaluate their potential in a new therapeutic approach to provide alternative therapies and improved outcomes for patients with aggressive pituitary tumors that do not respond to standard treatment. We perform a systematic literature search using the PubMed, Embase, and Scopus databases (search date was 2012–2023). Out of the 529 screened studies, 13 met the inclusion criteria, 7 related to the PI3K/AKT/mTOR pathway, and 7 to the RAF/MEK/ERK pathway (one study was used in both analyses). Understanding the specific factors involved in PT tumorigenesis provides opportunities for targeted therapies. We also review the possible new targeted therapies and the use of mTOR inhibitors and TKI in PT management. Although the RAF/MEK/ERK and PI3K/AKT/mTOR pathways play a pivotal role in the complex signaling network along with many interactions, further research is urgently needed to clarify the exact functions and the underlying mechanisms of these signaling pathways in the pathogenesis of pituitary adenomas and their role in its invasiveness and aggressive clinical outcome. |
format | Online Article Text |
id | pubmed-10341524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103415242023-07-14 The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review Derwich, Aleksandra Sykutera, Monika Bromińska, Barbara Rubiś, Błażej Ruchała, Marek Sawicka-Gutaj, Nadia Int J Mol Sci Review Pituitary tumors (PT) are mostly benign, although occasionally they demonstrate aggressive behavior, invasion of surrounding tissues, rapid growth, resistance to conventional treatments, and multiple recurrences. The pathogenesis of PT is still not fully understood, and the factors responsible for its invasiveness, aggressiveness, and potential for metastasis are unknown. RAF/MEK/ERK and mTOR signaling are significant pathways in the regulation of cell growth, proliferation, and survival, its importance in tumorigenesis has been highlighted. The aim of our review is to determine the role of the activation of PI3K/AKT/mTOR and RAF/MEK/ERK pathways in the pathogenesis of pituitary tumors. Additionally, we evaluate their potential in a new therapeutic approach to provide alternative therapies and improved outcomes for patients with aggressive pituitary tumors that do not respond to standard treatment. We perform a systematic literature search using the PubMed, Embase, and Scopus databases (search date was 2012–2023). Out of the 529 screened studies, 13 met the inclusion criteria, 7 related to the PI3K/AKT/mTOR pathway, and 7 to the RAF/MEK/ERK pathway (one study was used in both analyses). Understanding the specific factors involved in PT tumorigenesis provides opportunities for targeted therapies. We also review the possible new targeted therapies and the use of mTOR inhibitors and TKI in PT management. Although the RAF/MEK/ERK and PI3K/AKT/mTOR pathways play a pivotal role in the complex signaling network along with many interactions, further research is urgently needed to clarify the exact functions and the underlying mechanisms of these signaling pathways in the pathogenesis of pituitary adenomas and their role in its invasiveness and aggressive clinical outcome. MDPI 2023-06-30 /pmc/articles/PMC10341524/ /pubmed/37446128 http://dx.doi.org/10.3390/ijms241310952 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Derwich, Aleksandra Sykutera, Monika Bromińska, Barbara Rubiś, Błażej Ruchała, Marek Sawicka-Gutaj, Nadia The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review |
title | The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review |
title_full | The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review |
title_fullStr | The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review |
title_full_unstemmed | The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review |
title_short | The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review |
title_sort | role of activation of pi3k/akt/mtor and raf/mek/erk pathways in aggressive pituitary adenomas—new potential therapeutic approach—a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341524/ https://www.ncbi.nlm.nih.gov/pubmed/37446128 http://dx.doi.org/10.3390/ijms241310952 |
work_keys_str_mv | AT derwichaleksandra theroleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT sykuteramonika theroleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT brominskabarbara theroleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT rubisbłazej theroleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT ruchałamarek theroleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT sawickagutajnadia theroleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT derwichaleksandra roleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT sykuteramonika roleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT brominskabarbara roleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT rubisbłazej roleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT ruchałamarek roleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview AT sawickagutajnadia roleofactivationofpi3kaktmtorandrafmekerkpathwaysinaggressivepituitaryadenomasnewpotentialtherapeuticapproachasystematicreview |